Join to View Full Profile
1500 e duarteMonrovia, CA 91016
Jose Tinajero is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins University School of MedicineHematology/Oncology, 2020 - 2021
University of California, San DiegoGeneral/Acute Care Medicine, 2019 - 2020
University of California, San FranciscoPharmD, 2019
Publications & Presentations
PubMed
- FLAG-Ida-Venetoclax vs CLIA-venetoclax for relapsed and refractory AML during a fludarabine shortage: A single center experience.Jose Tinajero, Dat Ngo, Brian Lee, Hoim Kim, Brian Ball
Journal of Oncology Pharmacy Practice. 2026-04-01 - Real world outcomes of patients with secondary acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation after induction with liposomal daunorubi...Dat Ngo, Guneet Kaleka, Dongyun Yang, Sally Mokhtari, Jose Tinajero
Leukemia & Lymphoma. 2026-02-01 - Ponatinib in the treatment of acute lymphoblastic leukemia.Tamer Othman, Dat Ngo, Jose Tinajero, Ibrahim Aldoss
Future Oncology. 2025-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
